Drug Profile


Alternative Names: AHR 11190; AHR 11190B; MD 780209

Latest Information Update: 22 Jan 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Delalande
  • Developer AH Robins; Delalande
  • Class Antiemetics; Benzamides; Drug withdrawal therapies
  • Mechanism of Action Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Cognition disorders; Major depressive disorder; Nausea and vomiting; Psychotic disorders

Most Recent Events

  • 22 Jan 1997 Discontinued-Unspecified phase in Depression in USA (PO)
  • 22 Jan 1997 Discontinued-Unspecified phase in Emesis in USA (PO)
  • 25 Jun 1996 Discontinued-Unspecified phase in Cognition disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top